BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20216110)

  • 1. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.
    Wallemacq P; Maine GT; Berg K; Rosiere T; Marquet P; Aimo G; Mengozzi G; Young J; Wonigeit K; Kretschmer R; Wermuth B; Schmid RW
    Ther Drug Monit; 2010 Apr; 32(2):145-51. PubMed ID: 20216110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine metabolite cross-reactivity in different cyclosporine assays.
    Murthy JN; Yatscoff RW; Soldin SJ
    Clin Biochem; 1998 Apr; 31(3):159-63. PubMed ID: 9629489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity.
    Brate EM; Finley DM; Grote J; Holets-McCormack S; Ozaeta PF; Pacenti D; Peart JE; Piktel RE; Ramsay CS; Rupprecht KR; Saldana SC; Spring TG; Tetin SY; Trudeau BC; Wang P; Xie H
    Clin Biochem; 2010 Sep; 43(13-14):1152-7. PubMed ID: 20599875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer.
    Terrell AR; Daly TM; Hock KG; Kilgore DC; Wei TQ; Hernandez S; Weibe D; Fields L; Shaw LM; Scott MG
    Clin Chem; 2002 Jul; 48(7):1059-65. PubMed ID: 12089175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of EMIT Cyclosporine Assay for use with whole blood.
    Beresini MH; Davalian D; Alexander S; Toton-Quinn R; Barnett B; Cerelli MJ; Hu MW; Berger DE; Blohm WP; Jaklitsch A
    Clin Chem; 1993 Nov; 39(11 Pt 1):2235-41. PubMed ID: 8222215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
    Toole B; Gechtman C; Dreier J; Kuhn J; Gutierrez MR; Barrett A; Niederau C
    Clin Lab; 2015; 61(9):1303-15. PubMed ID: 26554251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring cyclosporine of pre-dose and post-dose samples using nonextraction homogeneous immunoassay.
    Loor R; Pope L; Boyd R; Wood K; Bodepudi V
    Ther Drug Monit; 2004 Feb; 26(1):58-67. PubMed ID: 14749552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
    Amann S; Parker TS; Levine DM
    Ther Drug Monit; 2009 Apr; 31(2):273-6. PubMed ID: 19142177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry.
    Falck P; Guldseth H; Asberg A; Midtvedt K; Reubsaet JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):345-52. PubMed ID: 17301005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay.
    Butch AW; Fukuchi AM
    J Anal Toxicol; 2004 Apr; 28(3):204-10. PubMed ID: 15107152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists Study.
    Soldin SJ; Steele BW; Witte DL; Wang E; Elin RJ;
    Arch Pathol Lab Med; 2003 Jan; 127(1):19-22. PubMed ID: 12521361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood.
    Yatscoff RW; Copeland KR; Faraci CJ
    Clin Chem; 1990 Nov; 36(11):1969-73. PubMed ID: 2242580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry.
    Simpson J; Zhang Q; Ozaeta P; Aboleneen H
    Ther Drug Monit; 1998 Jun; 20(3):294-300. PubMed ID: 9631926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
    Günther V; Mueller D; von Eckardstein A; Saleh L
    Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
    Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
    Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function.
    Liu WT; Levy GA; Wong PY
    Ther Drug Monit; 1995 Oct; 17(5):479-86. PubMed ID: 8585111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress report of an external quality assessment scheme for cyclosporine assay.
    Zucchelli GC; Pilo A; Chiesa MR; Scarlattini M; Bizollon CA
    Ther Drug Monit; 1996 Jun; 18(3):273-9. PubMed ID: 8738767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of architect I 2000 for determination of cyclosporine with axsym.
    Serdarevic N; Zunic L
    Acta Inform Med; 2012 Dec; 20(4):214-7. PubMed ID: 23378685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cyclosporine assays using sequential samples from selected transplant patients.
    LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW
    Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.